Clinical Data Event - Watch List 5/24/13

Updated Clinical Data Watch List as of: 5/24/13.

The following is a list of companies with near term (within one year) phase III clinical data read-outs pending:

Acadia Pharmaceuticals, Inc. (ACAD)
Pimavanserin 020 - http://www.biotechnologyevents.com/node/3027 (COMPLETED)

Alkermes, Inc. (ALKS)
ALKS-37 - http://www.biotechnologyevents.com/node/4193 (COMPLETED)

Amgen, Inc. (AMGN)
OncoVEX GM-CSF - http://www.biotechnologyevents.com/node/3673

Amicus Therapeutics, Inc. (FOLD)
AT2220 - http://www.biotechnologyevents.com/node/1310 (COMPLETED)
Amigal 011 - http://www.biotechnologyevents.com/node/2482 (COMPLETED)
Amigal 013 - http://www.biotechnologyevents.com/node/3134 (COMPLETED)
Amigal 012 - http://www.biotechnologyevents.com/node/2484

ArQule, Inc. (ARQL)
Trivantinib NSCLC MARQUEE- http://www.biotechnologyevents.com/node/ (DISCONTINUED)
Trivantinib CRC - http://www.biotechnologyevents.com/node/5361 (COMPLETED)

AVEO Oncology (AVEO)
Tivozanib BATON-RCC - http://www.biotechnologyevents.com/node/5435
Tivozanib phase III Renal - http://www.biotechnologyevents.com/node/5431

BioCryst Pharmaceuticals Inc. (BCRX)
Peramivir IV 301 - http://www.biotechnologyevents.com/node/2536 (COMPLETED)
BCX-5191 - http://www.biotechnologyevents.com/node/5749 (DISCONTINUED)

Biogen Idec, Inc. (BIIB)
BG-12 (dimethyl fumurate) EXPLORE - http://www.biotechnologyevents.com/node/2906
Factor VIII (rFVIIIFc) A-LONG - http://www.biotechnologyevents.com/node/3361 (COMPLETED)
Factor IX B-LONG - http://www.biotechnologyevents.com/node/2554 (COMPLETED)
KNS-760704 (dexpramipexole) EMPOWER - http://www.biotechnologyevents.com/node/3730 (COMPLETED)
TYSABRI (natalizumab) SURPASS - http://www.biotechnologyevents.com/node/2729
PEGylated Interferon Beta-1a ADVANCE - http://www.biotechnologyevents.com/node/1720 (COMPLETED)

BioMarin Pharmaceuticals, Inc. (BMRN)
PEG-PAL - http://www.biotechnologyevents.com/node/5754 COMPLETED)
GALNS - http://www.biotechnologyevents.com/node/3721 COMPLETED)
BMN-673 - http://www.biotechnologyevents.com/node/5756
BMN-701 - http://www.biotechnologyevents.com/node/4793
Kuvan PKU-016 - http://www.biotechnologyevents.com/node/3089 COMPLETED)
GALNS < age 5 - http://www.biotechnologyevents.com/node/4703
Firdapse - http://www.biotechnologyevents.com/node/4039

Celldex Therapeutics, Inc. (CLDX)
CDX-011 at ASCO 6/01 - 6/05 - http://www.biotechnologyevents.com/node/3074 (COMPLETE)

Cell Therapeutics Inc. (CTIC)
OPAXIO GOG-0212 - http://www.biotechnologyevents.com/node/192

Celsion Corporation (CLSN)
ThermoDox HEAT - http://www.biotechnologyevents.com/node/5534 (COMPLETED)

Depomed, Inc. (DEPO)
Serada (gabapentin) BREEZE-3 - http://www.biotechnologyevents.com/node/3692 (COMPLETED)

Dyax Corporation (DYAX)
Kalbitor ACE Inhibitor angioedema - http://www.biotechnologyevents.com/node/3329 (COMPLETED)

Exelixis, Inc. (EXEL)
Cabozantinib COMET-2 - http://www.biotechnologyevents.com/node/5412
Cabozantinib COMET-1 - http://www.biotechnologyevents.com/node/5413

Geron Corporation (GERN)
Imetelstat metastatic breast cancer - http://www.biotechnologyevents.com/node/5788 (DISCONTINUED)
Imetelstat NSCLC - http://www.biotechnologyevents.com/node/5787
Imetelstat Essential Thrombocythemia - http://www.biotechnologyevents.com/node/5789 (COMPLETED)
Imetelstat Multiple Myeloma - http://www.biotechnologyevents.com/node/5790
GRN1005 GRABM-L - http://www.biotechnologyevents.com/node/5791 (DISCONTINUED)
GRN1005 GRABM-B - http://www.biotechnologyevents.com/node/5792 (DISCONTINUED)

GTx, Inc. (GTXI)
Ostarine POWER-1 - http://www.biotechnologyevents.com/node/5089
Ostarine POWER-2 - http://www.biotechnologyevents.com/node/5088

ImmunoGen, Inc. (IMGN)
Lorvotuzumab - http://www.biotechnologyevents.com/node/5451
SAR3419 - http://www.biotechnologyevents.com/node/5456

Incyte Pharmaceuticals, Inc. (INCY)
INCB-28050 (LY3009104) RA - http://www.biotechnologyevents.com/node/3328 (COMPLETED)
INCB-28050 (LY3009104) Psoriasis - http://www.biotechnologyevents.com/node/5505
Ruxolitinib PCV - http://www.biotechnologyevents.com/node/3312

Keryx Biopharmaceuticals, Inc. (KERX)
Perifosine XPECT - http://www.biotechnologyevents.com/node/2795 (COMPLETED)
Zerenex - http://www.biotechnologyevents.com/node/3097 (COMPLETED)

Lexicon Pharmaceuticals, Inc. - (LXRX)
LX2931 - http://www.biotechnologyevents.com/node/5520
Telotristat etiprate Carcinoid Syndrome - http://www.biotechnologyevents.com/node/5523 (COMPLETED)
Telotristat etiprate Ulcerative colitis - http://www.biotechnologyevents.com/node/5519 (COMPLETED)
LX7101 - http://www.biotechnologyevents.com/node/5522
LX4211 - http://www.biotechnologyevents.com/node/5518
LX1033 - http://www.biotechnologyevents.com/node/5524

Ligand Pharmaceuticals, Inc. (LGND)
Carbamazepine IV - http://www.biotechnologyevents.com/node/5064

MannKind Corporation (MNKD)
Afreeza - http://www.biotechnologyevents.com/node/4291
Afreeza - http://www.biotechnologyevents.com/node/4292

Nektar Therapeutics, Inc. (NKTR)
NKTR-102 Ovarian Cancer - http://www.biotechnologyevents.com/node/3229 (COMPLETED)
NKTR-118 OIC - http://www.biotechnologyevents.com/node/3837 (COMPLETED)
NKTR-118 OIC - http://www.biotechnologyevents.com/node/4302
NKTR-118 OIC - http://www.biotechnologyevents.com/node/4298 (COMPLETED)
NKTR-118 OIC - http://www.biotechnologyevents.com/node/4301
NKTR-118 OIC - http://www.biotechnologyevents.com/node/4299

OncoGenex Pharmaceuticals, Inc. (OGXI)
OGX-427 Prostate PR-01 - http://www.biotechnologyevents.com/node/5307

Oncothyreon In. (ONTY)
STIMUVAX START Trial - http://www.biotechnologyevents.com/node/5003 (COMPLETED)

Onyx Pharmaceuticals, Inc. (ONXX)
Nexavar MISSION - http://www.biotechnologyevents.com/node/2217 (COMPLETED)
Nexavar - SEARCH - http://www.biotechnologyevents.com/node/2216 (COMPLETED)

Osiris Therapeutics, Inc. (OSIR)
Prochymal Post AMI - http://www.biotechnologyevents.com/node/5420 (COMPLETED)
Prochymal Crohn's Osiris 603 - http://www.biotechnologyevents.com/node/5421
Prochymal Crohn's Osiris 611 - http://www.biotechnologyevents.com/node/5418

Peregrine Pharmaceuticals, Inc.(PPHM)
Bavituximab second-line NSCLC - http://www.biotechnologyevents.com/node/4053 (COMPLETED)
Bavituximab second-line NSCLC - http://www.biotechnologyevents.com/node/5865 (COMPLETED)
Bavituximab pancreatic - http://www.biotechnologyevents.com/node/4054 (COMPLETED)
Bavituximab first-line NSCLC - http://www.biotechnologyevents.com/node/4122 (COMPLETED)

Pharmacyclics, Inc. (PCYC)
PCI-32765 - http://www.biotechnologyevents.com/node/4728

Pozen, Inc. (POZN)
PA-32540 (301) - http://www.biotechnologyevents.com/node/2235 (COMPLETED)
PA-32540 (302) - http://www.biotechnologyevents.com/node/2234 (COMPLETED)

Regeneron Pharmaceuticals Inc. (REGN)
Zaltrap (Aflibercept) Prostate Ca. - http://www.biotechnologyevents.com/node/4125 (COMPLETED)

Rigel Pharmaceuticals, Inc. (RIGL)
Fostamatinib OSKIRA-1 - http://www.biotechnologyevents.com/node/3346
Fostamatinib OSKIRA-2 - http://www.biotechnologyevents.com/node/3347
Fostamatinib OSKIRA-3 - http://www.biotechnologyevents.com/node/3348

Sangamo BioSciences, Inc. - (SGMO)
SB-728-T - http://www.biotechnologyevents.com/node/5801
SB-728-T - http://www.biotechnologyevents.com/node/5802

Synta Pharmaceuticals, Inc. (SNTA)
Ganetespib (NSCLC) GALAXY - http://www.biotechnologyevents.com/node/3814 (COMPLETED)

The Medicine Company, Inc. (MDCO)
Oritavancin SOLO-I program - http://www.biotechnologyevents.com/node/3784 (COMPLETED)
Oritavancin SOLO-II program - http://www.biotechnologyevents.com/node/3785
Cangrelor CHAMPION PHOENIX - http://www.biotechnologyevents.com/node/3279 (COMPLETED)
MDCO-2010 - http://www.biotechnologyevents.com/node/5866 (COMPLETED)

Threshold Pharmaceuticals, Inc. (THLD)
TH-302 Pancreatic 404 - http://www.biotechnologyevents.com/node/5382 (COMPLETED)
TH-302 Sarcoma 406 - http://www.biotechnologyevents.com/node/5381
TH-302 Renal - http://www.biotechnologyevents.com/node/5384
TH-302 GIST - http://www.biotechnologyevents.com/node/5383

Transcept Pharmaceuticals, Inc. (TSPT)
TO-2061 (Ondansetron) - http://www.biotechnologyevents.com/node/5881 (COMPLETED)

Vanda Pharmaceuticals, Inc. (VNDA)
Tasimelteon SET - http://www.biotechnologyevents.com/node/4859 (COMPLETED)
Tasimelteon RESET - http://www.biotechnologyevents.com/node/4858 (COMPLETED)
Tasimelteon MAGELLAN - http://www.biotechnologyevents.com/node/3976 (COMPLETED)

Vertex Pharmaceuticals, Inc. (VRTX)
VX-770/VX-809 combo - http://www.biotechnologyevents.com/node/4909 (COMPLETED)

Vical Incorporated (VICL)
Allovectin - http://www.biotechnologyevents.com/node/3953

XenoPort, Inc. (XNPT)
Arbaclofen placarbil - http://www.biotechnologyevents.com/node/4293

ZIOPHARM Oncology, Inc. (ZIOP)
Palifosfamide PICASSO-3 - http://www.biotechnologyevents.com/node/5367

Biotechnology Events

Navigation

Clinical Data Event - Watch List 5/24/13